Company logo

OCGN - Ocugen, Inc.

NASDAQ -> Healthcare -> Biotechnology
Malvern, United States
Type: Equity

OCGN price evolution
OCGN
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Jan 2023
Current assets
Cash $53.48 $70.58 $68.26 $77.56
Short term investments $8.46 $13.37
Net receivables
Inventory
Total current assets $56.56 $73.45 $84.4 $98.49
Long term investments
Property, plant & equipment $14.47 $11.72 $7.95 $9.96
Goodwill & intangible assets
Total noncurrent assets $18.13 $15.52 $11.9 $10.14
Total investments $8.46 $13.37
Total assets $74.69 $88.98 $96.3 $108.63
Current liabilities
Accounts payable $2.92 $3.88 $8.09 $8.06
Deferred revenue
Short long term debt $1.82 $1.79 $1.77 $0.5
Total current liabilities $11.14 $13.46 $15.68 $18.46
Long term debt $4.66 $4.78 $4.51 $2.29
Total noncurrent liabilities $5.16 $5.24 $4.82 $6.12
Total debt $6.47 $6.57 $6.28 $6.37
Total liabilities $16.29 $18.7 $20.5 $24.58
Shareholders' equity
Retained earnings -$266.6 -$252.44 -$229.52 -$213.02
Other shareholder equity $0.03 $0.02 $0.03 $0.03
Total shareholder equity $58.4 $70.28 $75.8 $84.05
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $77.56 $95.11 $24.19 $7.6
Short term investments $13.37
Net receivables
Inventory
Total current assets $98.49 $102.65 $25.88 $15.77
Long term investments
Property, plant & equipment $9.96 $1.16 $0.63 $0.22
Goodwill & intangible assets
Total noncurrent assets $10.14 $3.12 $1.5 $1.04
Total investments $13.37
Total assets $108.63 $105.76 $27.38 $16.81
Current liabilities
Accounts payable $8.06 $2.31 $0.4 $1.9
Deferred revenue
Short long term debt $0.5 $0.36 $0.28 $0.17
Total current liabilities $18.46 $7 $3.61 $4.54
Long term debt $2.29 $2.94 $2.21 $1.24
Total noncurrent liabilities $6.12 $2.94 $2.21 $1.25
Total debt $6.37 $3.31 $2.49 $1.41
Total liabilities $24.58 $9.94 $5.83 $5.79
Shareholders' equity
Retained earnings -$213.02 -$131.67 -$73.3 -$51.48
Other shareholder equity $0.03 -$0.05 -$0.05
Total shareholder equity $84.05 $95.82 $21.55 $11.02
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $6.34 $14.17 $9.56 $17.21
Selling, general & administrative $9.08 $9.56 $8.19 $6.94
Total operating expenses $15.42 $23.73 $17.75 $24.15
Operating income -$15.42 -$23.73 -$17.75 -$24.15
Income from continuing operations
EBIT -$14.16 -$22.93 -$16.5 -$21.94
Income tax expense
Interest expense
Net income
Net income -$14.16 -$22.93 -$16.5 -$21.94
Income (for common shares) -$14.16 -$22.93 -$16.5 -$21.94
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $0.04
Cost of revenue
Gross Profit $0.04
Operating activities
Research & development $49.76 $35.11 $6.35 $8.09
Selling, general & administrative $35.11 $22.92 $7.97 $6.08
Total operating expenses $84.87 $58.03 $21.33 $14.16
Operating income -$84.87 -$58.03 -$21.28 -$14.16
Income from continuing operations
EBIT -$81.35 -$58.34 -$21.1 -$18.47
Income tax expense -$0.05
Interest expense $0.08 $0.72 $1.77
Net income
Net income -$81.35 -$58.37 -$21.82 -$20.24
Income (for common shares) -$81.35 -$58.37 -$34.37 -$20.24
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$14.16 -$22.93 -$16.5 -$21.94
Operating activities
Depreciation $0.31 $0.31 $0.3 $0.3
Business acquisitions & disposals
Stock-based compensation $2.17 $2.63 $2.69 $2.67
Total cash flows from operations -$13.71 -$18.81 -$18.24 -$16.91
Investing activities
Capital expenditures -$3.37 -$2.78 -$1.61 -$2.02
Investments $8.5 $5.05 -$13.27
Total cash flows from investing -$3.37 $5.72 $3.44 -$15.29
Financing activities
Dividends paid
Sale and purchase of stock -$0.04 $14.91 $5.56 $8.12
Net borrowings $0.49 -$0.06
Total cash flows from financing -$0.04 $15.4 $5.5 $8.18
Effect of exchange rate $0.01 -$0 -$0 -$0.01
Change in cash and equivalents -$17.1 $2.32 -$9.3 -$24.04
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$81.35 -$58.37 -$21.82 -$20.24
Operating activities
Depreciation $1.07 $0.59 $0.29 $0.31
Business acquisitions & disposals -$0.13 -$2.33
Stock-based compensation $10.54 $6.96 $0.66 $0.88
Total cash flows from operations -$60.08 -$47.94 -$14.71 -$16.89
Investing activities
Capital expenditures -$4.46 -$0.94 -$0.31 -$0.03
Investments -$12.51
Total cash flows from investing -$16.97 -$1.82 -$0.31 -$2.36
Financing activities
Dividends paid
Sale and purchase of stock $59.02 $120.69 $36.34 $23.68
Net borrowings $0.46 -$0.01 -$4.73 $1.38
Total cash flows from financing $59.48 $120.68 $31.61 $25.07
Effect of exchange rate $0.03
Change in cash and equivalents -$17.55 $70.92 $16.6 $5.82
Fundamentals
Market cap $246.24M
Enterprise value $199.24M
Shares outstanding 256.50M
Revenue $0.00
EBITDA -$74.30M
EBIT -$75.52M
Net Income -$75.52M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -3.26
EV/Sales N/A
EV/EBITDA -2.68
EV/EBIT -2.64
P/S ratio N/A
P/B ratio 4.22
Book/Share 0.23
Cash/Share 0.21
EPS -$0.29
ROA -81.96%
ROE -104.70%
Debt/Equity 0.29
Net debt/EBITDA 0.50
Current ratio 5.08
Quick ratio 5.08